Rapid communicationCannabinoid CB1 receptor upregulation in a rat model of chronic neuropathic pain
Section snippets
Acknowledgements
We thank I. Flocke, F. Juengerkes, B. Koenig, I. Kruse, and B. Tretter for expert technical assistance and Dr P. Reeh (Department of Physiology, University of Erlangen-Nuernberg, Germany) for critical reading of the manuscript.
References (9)
- et al.
The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
Neurosci. Lett.
(1997) - et al.
The endocannabinoid system as a target for therapeutic drugs
TIPS
(2000) - et al.
A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats
J. Immunol. Methods
(1994) - et al.
Heat shock protein 27: developmental regulation and expression after peripheral nerve injury
J. Neurosci.
(1998)
Cited by (96)
Down-regulation of NR2B receptors contributes to the analgesic and antianxiety effects of enriched environment mediated by endocannabinoid system in the inflammatory pain mice
2022, Behavioural Brain ResearchCitation Excerpt :The CB1 receptor is expressed in the thalamus [2]. The thalamic cannabinoid CB1 receptors are up-regulated in a rat model of chronic neuropathic pain, which maybe contribute to the increased analgesic efficacy of cannabinoids in chronic pain [60], but CB1 receptors did not altered in the present study (data did not shown). A recent study found that the CB1 receptors located at the incerta-thalamic circuit terminals were critical elements in pain control [61].
Medical Cannabis for the Treatment of Inflammatory Bowel Disease
2017, Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and TreatmentCannabinoids and Pain: Sites and Mechanisms of Action
2017, Advances in PharmacologyCitation Excerpt :This effect was blocked by direct administration of rimonabant into the nucleus reticularis gigantocellularis pars, suggesting that increased endocannabinoid tone in neuropathic rats can modulate nociceptive behavior (Monhemius et al., 2001). In the thalamus, CB1R mRNA is upregulated in a rat model of neuropathic pain (Siegling, Hofmann, Denzer, Mauler, & De Vry, 2001). Potentially, upregulation of thalamic CB1R in neuropathic pain states may serve to enhance the analgesic effects of cannabinoids under these conditions.
Cannabinoids and autoimmune diseases: A systematic review
2016, Autoimmunity ReviewsDissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB<inf>1</inf>-cannabinoid receptor in the ventral mesencephalon
2015, European Journal of PharmacologyCitation Excerpt :In experimental models of chronic pain, there is an increase in the expression of these receptors (Manzanares et al., 2006). For example, models of neuropathic pain stimulate the expression and regulation of CB1 receptors in structures involved in pain processing, such as the superficial laminas of the dorsal horn of the spinal cord (Lim et al., 2003) and contralateral dorsal thalamic nuclei (Siegling et al., 2001). The aim of the present study was to investigate the effects of central administration of CBD into the substantia nigra, pars reticulata (SNpr), on GABAA receptor blockade-induced panic-like responses organised by the dorsal midbrain.
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy
2015, Journal of Pain